Literature DB >> 23544269

Simple and rapid quantitation of 21 bile acids in rat serum and liver by UPLC-MS-MS: effect of high fat diet on glycine conjugates of rat bile acids.

Yudai Suzuki1, Rina Kaneko, Mina Nomura, Hisao Naito, Kazuya Kitamori, Tamie Nakajima, Tadashi Ogawa, Hideki Hattori, Hiroshi Seno, Akira Ishii.   

Abstract

In this report, we present a simple and rapid method for analysis of 21 kinds of bile acids and the conjugates in rat serum and liver samples by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS-MS) in the negative ionization mode, using cholic-2, 2, 4, 4-d4 acid as internal standard. After liquid-liguid extraction from serum and liver samples, specimens were analyzed by UPLC equipped with an Acquity TQD tandem quadrupole mass spectrometer. All of the 21 bile acids were sufficiently separated within 5 min. For most bile acids, calibration curves showed good linearities in the range of 0.25 to 5000 ng/mL for serum samples, 2.5 ng/g to 50 microg/g for liver samples. The limits of detection (LOD) were estimated to be less than 0.25 to 7.5 ng/mL in serum, less than 2.5 to 10 ng/g in liver samples. The present method was validated with respect to repeatability; the coefficient of variation (CV) values were less than 26.7% in the serum and 25.9% in the liver. In the animal study, we compared 21 bile acids in the serum and liver samples of the stroke-prone spontaneously hypertensive (SHRSP) rats fed with control (SP) diet or high-fat and high-cholesterol-containing (HFC) diet. By feeding with HFC diet, the glycine conjugates of some bile acids significantly increased and the taurine conjugate of ulsodeoxicolate (TUDC) decreased in serum and liver samples. Our results suggest that the change of bile acid profiles could be applied for the diagnosis of non-alcoholic fatty liver disease (NAFLD).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23544269      PMCID: PMC4345703     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  22 in total

Review 1.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

2.  Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Ines Burkard; Arnold von Eckardstein; Katharina M Rentsch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-22       Impact factor: 3.205

3.  Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.

Authors:  Kazuya Kitamori; Hisao Naito; Hazuki Tamada; Miya Kobayashi; Daisuke Miyazawa; Yuko Yasui; Kunihiro Sonoda; Satoru Tsuchikura; Naomi Yasui; Katsumi Ikeda; Takashi Moriya; Yukio Yamori; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2011-08-19       Impact factor: 3.674

4.  Ultra performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: application to experimental toxicology studies.

Authors:  Elizabeth J Want; Muireann Coen; Perrine Masson; Hector C Keun; Jake T M Pearce; Michael D Reily; Donald G Robertson; Cynthia M Rohde; Elaine Holmes; John C Lindon; Robert S Plumb; Jeremy K Nicholson
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

Review 5.  Hepatobiliary transporters and drug-induced cholestasis.

Authors:  Christiane Pauli-Magnus; Peter J Meier
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

Review 6.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 7.  Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors.

Authors:  John Y L Chiang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-03       Impact factor: 4.052

8.  High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma.

Authors:  Xiaoqiang Xiang; Yi Han; Mikko Neuvonen; Jouko Laitila; Pertti J Neuvonen; Mikko Niemi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-01-01       Impact factor: 3.205

9.  Determination of bile acids in biological fluids by liquid chromatography-electrospray tandem mass spectrometry.

Authors:  S Perwaiz; B Tuchweber; D Mignault; T Gilat; I M Yousef
Journal:  J Lipid Res       Date:  2001-01       Impact factor: 5.922

Review 10.  Bile acids: regulation of synthesis.

Authors:  John Y L Chiang
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

View more
  16 in total

1.  Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid.

Authors:  Xiping Cui; Natalia Vasylieva; Ding Shen; Bogdan Barnych; Jun Yang; Qiyi He; Zhengyun Jiang; Suqing Zhao; Bruce D Hammock
Journal:  Analyst       Date:  2018-04-30       Impact factor: 4.616

Review 2.  The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Monica D Chow; Yi-Horng Lee; Grace L Guo
Journal:  Mol Aspects Med       Date:  2017-05-05

3.  A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model.

Authors:  Xiaofang Jia; Yudai Suzuki; Hisao Naito; Husna Yetti; Kazuya Kitamori; Yumi Hayashi; Rina Kaneko; Mina Nomura; Yukio Yamori; Kei Zaitsu; Masashi Kato; Akira Ishii; Tamie Nakajima
Journal:  Dig Dis Sci       Date:  2014-01-22       Impact factor: 3.199

Review 4.  A review of analytical platforms for accurate bile acid measurement.

Authors:  Mainak Dutta; Jingwei Cai; Wei Gui; Andrew D Patterson
Journal:  Anal Bioanal Chem       Date:  2019-05-24       Impact factor: 4.142

5.  Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.

Authors:  Ikumi Sato; Shusei Yamamoto; Mai Kakimoto; Moe Fujii; Koki Honma; Shota Kumazaki; Mami Matsui; Hinako Nakayama; Sora Kirihara; Shang Ran; Shinichi Usui; Ryoko Shinohata; Kazuya Kitamori; Satoshi Hirohata; Shogo Watanabe
Journal:  Pharmacol Rep       Date:  2022-07-12       Impact factor: 3.919

6.  Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation.

Authors:  Jaehyeok Lee; Chul Haeng Lee; Jong-Geon Lee; So Yeon Jeon; Min-Koo Choi; Im-Sook Song
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

7.  Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.

Authors:  Hisao Naito; Xiaofang Jia; Husna Yetti; Yukie Yanagiba; Hazuki Tamada; Kazuya Kitamori; Yumi Hayashi; Dong Wang; Masashi Kato; Akira Ishii; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2016-05-21       Impact factor: 3.674

8.  Taurolithocholic acid but not tauroursodeoxycholic acid rescues phagocytosis activity of bone marrow-derived macrophages under inflammatory stress.

Authors:  Siyu Wu; Lorenzo Romero-Ramírez; Jörg Mey
Journal:  J Cell Physiol       Date:  2021-10-27       Impact factor: 6.513

9.  Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver Injury.

Authors:  Francis S Wolenski; Andy Z X Zhu; Mike Johnson; Shaoxia Yu; Yuu Moriya; Takuya Ebihara; Vilmos Csizmadia; Jessica Grieves; Martin Paton; Mingxiang Liao; Christopher Gemski; Liping Pan; Majid Vakilynejad; Yvonne P Dragan; Swapan K Chowdhury; Patrick J Kirby
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

10.  Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.

Authors:  Husna Yetti; Hisao Naito; Yuan Yuan; Xiaofang Jia; Yumi Hayashi; Hazuki Tamada; Kazuya Kitamori; Katsumi Ikeda; Yukio Yamori; Tamie Nakajima
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.